Gut bacteria may shield nerves from chemo damage – a trial puts it to the test
Symptom relief
Not yet recruiting
This phase III trial tests whether a daily probiotic supplement, OXXYSLAB®, can reduce peripheral neuropathy—nerve damage causing pain and numbness—in people with stage III colon cancer receiving oxaliplatin-based chemotherapy (FOLFOX or XELOX). About 130 participants will take e…
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC